vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $45.6M, roughly 1.7× Primis Financial Corp.). Primis Financial Corp. runs the higher net margin — 16.0% vs 7.4%, a 8.6% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 13.0%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
FRST vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $76.2M |
| Net Profit | $7.3M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 16.0% | 7.4% |
| Revenue YoY | — | 25.5% |
| Net Profit YoY | 200.0% | 30.7% |
| EPS (diluted) | $0.30 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $76.2M | ||
| Q3 25 | $41.0M | $71.9M | ||
| Q2 25 | $43.2M | $63.1M | ||
| Q1 25 | $58.7M | $59.1M | ||
| Q4 24 | $38.8M | $60.7M | ||
| Q3 24 | $37.3M | $58.0M | ||
| Q2 24 | $35.7M | $55.0M |
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | $5.6M | ||
| Q3 25 | $6.8M | $3.5M | ||
| Q2 25 | $2.4M | $3.2M | ||
| Q1 25 | $22.6M | $2.6M | ||
| Q4 24 | $-26.2M | $4.3M | ||
| Q3 24 | $1.2M | $3.9M | ||
| Q2 24 | $3.4M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | 11.0% | ||
| Q3 25 | 21.3% | 7.8% | ||
| Q2 25 | 6.9% | 8.1% | ||
| Q1 25 | 41.9% | 6.5% | ||
| Q4 24 | -123.0% | 10.6% | ||
| Q3 24 | -3.1% | 9.7% | ||
| Q2 24 | 7.8% | 6.6% |
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | 7.4% | ||
| Q3 25 | 16.7% | 4.9% | ||
| Q2 25 | 5.6% | 5.0% | ||
| Q1 25 | 38.6% | 4.4% | ||
| Q4 24 | -100.3% | 7.1% | ||
| Q3 24 | 3.3% | 6.7% | ||
| Q2 24 | 9.6% | 2.7% |
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $0.14 | ||
| Q3 25 | $0.28 | $0.09 | ||
| Q2 25 | $0.10 | $0.08 | ||
| Q1 25 | $0.92 | $0.06 | ||
| Q4 24 | $-0.95 | $0.10 | ||
| Q3 24 | $0.05 | $0.10 | ||
| Q2 24 | $0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $427.2M | $141.5M |
| Total Assets | $4.3B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $13.5M | ||
| Q3 25 | $63.9M | $11.1M | ||
| Q2 25 | $94.1M | $20.0M | ||
| Q1 25 | $57.0M | $10.2M | ||
| Q4 24 | $64.5M | $17.5M | ||
| Q3 24 | $77.3M | $11.3M | ||
| Q2 24 | $66.6M | $8.8M |
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $141.5M | ||
| Q3 25 | $382.2M | $133.6M | ||
| Q2 25 | $376.4M | $139.7M | ||
| Q1 25 | $375.6M | $134.8M | ||
| Q4 24 | $351.8M | $131.4M | ||
| Q3 24 | $381.0M | $125.0M | ||
| Q2 24 | $376.0M | $119.4M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $199.2M | ||
| Q3 25 | $4.0B | $202.4M | ||
| Q2 25 | $3.9B | $184.6M | ||
| Q1 25 | $3.7B | $178.1M | ||
| Q4 24 | $3.7B | $177.1M | ||
| Q3 24 | $4.0B | $169.5M | ||
| Q2 24 | $4.0B | $163.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $18.4M | ||
| Q3 25 | $-11.4M | $18.4M | ||
| Q2 25 | $-41.0M | $12.3M | ||
| Q1 25 | $34.4M | $2.9M | ||
| Q4 24 | $19.5M | $15.0M | ||
| Q3 24 | $6.1M | $12.7M | ||
| Q2 24 | $52.3M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | $18.3M | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | 47.3% | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | 3.1% | 19.5% | ||
| Q3 24 | 0.0% | 19.0% | ||
| Q2 24 | 0.0% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | 3.27× | ||
| Q3 25 | -1.67× | 5.23× | ||
| Q2 25 | -16.82× | 3.88× | ||
| Q1 25 | 1.52× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 4.93× | 3.29× | ||
| Q2 24 | 15.21× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
VMD
Segment breakdown not available.
